Global Assisted Reproductive Technology Market Report and Forecast 2024-2032
Market Report I 2023-09-12 I 160 Pages I EMR Inc.
Global Assisted Reproductive Technology Market Report and Forecast 2024-2032
Global Assisted Reproductive Technology Outlook
The global assisted reproductive technology market size was valued at USD 14.8 billion in 2023, driven by the increasing infertility issues across the globe. The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 to achieve a value of USD 21.8 billion by 2032.
Assisted Reproductive Technology: Introduction
Assisted Reproductive Technology (ART) encompasses medical procedures that aid in achieving pregnancy when natural conception is challenging. Techniques include in vitro fertilization (IVF), where an egg is fertilized outside the body, and intracytoplasmic sperm injection (ICSI), where a single sperm is injected into an egg. ART assists couples facing fertility issues, allowing for conception and pregnancy by overcoming barriers such as infertility, genetic disorders, or reproductive challenges.
Key Trends in the Global Assisted Reproductive Technology Market
The global Assisted Reproductive Technology (ART) market has witnessed dynamic trends reshaping the landscape of fertility treatments. Technological strides have led to continuous refinements in ART techniques, such as enhanced embryo culture and advanced genetic screening.
A notable shift in societal attitudes is evident, with increased acceptance of third-party reproduction methods, including egg and sperm donation, surrogacy, and gestational carriers. The rising age of first-time parents has propelled a surge in couples seeking ART solutions to address age-related fertility challenges. Globalization of ART services is on the rise, with individuals seeking treatments in countries offering advanced technologies or more favourable regulations.
There is a growing emphasis on addressing male infertility, leading to advancements in diagnostics and treatments for male reproductive health. Increasing regulatory oversight reflects a commitment to maintaining ethical standards and patient safety. Some regions have witnessed expanded insurance coverage for fertility treatments, contributing to greater accessibility.
The integration of artificial intelligence in fertility clinics is revolutionizing data analysis, predictive modelling, and treatment optimization. Education and awareness initiatives have played a crucial role in informing the public about fertility preservation options and the availability of ART services.
The impact of the COVID-19 pandemic has been noteworthy, causing temporary disruptions in fertility clinic operations and treatment plans, followed by a resurgence in demand. These multifaceted trends collectively underscore the evolving landscape of ART, emphasizing innovation, accessibility, and a broader understanding of reproductive health. For the latest insights in 2023, consulting recent industry reports and market analyses is advised.
Global Assisted Reproductive Technology Market Segmentation
Market Breakup by Procedure
- Fresh Donor
- Fresh Nondonor
- Frozen Donor
- Frozen Nondonor
- Embryo/Egg Banking
Market Breakup by Age
- Women Younger Than Age 35
- Women Older Than Age 35
Market Breakup by Application
- Artificial Insemination - Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Surrogacy
- Ovulation Induction
- Others
Market Breakup by End User
- Hospitals
- Fertility Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Assisted Reproductive Technology Market Overview
The ART market has seen increased demand due to factors such as delayed parenthood, rising infertility rates, and advancements in reproductive technologies. Procedures like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) have become more prevalent in addressing fertility challenges.
The United States has led the assisted reproductive technology market share owing to pioneering research and development in reproductive technologies and fertility treatments.
There is a high level of awareness and acceptance of ART procedures among the U.S. population, leading to a robust demand for these services. Moreover, the country's advanced healthcare infrastructure supports the widespread availability and accessibility of ART services. Some insurance plans in the U.S. cover fertility treatments as well, making these services more financially accessible to a larger population.
We can expect the Asia Pacific (APAC) region to grow rapidly in the forecast period. The implementation of awareness campaigns to educate the public about infertility, available treatments, and the success rates of ART procedures are some of the major factors for growth.
There has been regular development and enhancement of healthcare infrastructure to provide state-of-the-art fertility clinics and laboratories equipped with the latest technologies. Implementing measures to make ART more affordable and accessible to a wider demographic, possibly through insurance coverage or government initiatives is also in the works.
Global Assisted Reproductive Technology Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- California Cryobank
- Bloom Fertility Centre
- Anecova
- CooperSurgical
- Merck KGaA
- Ferring B.V.
- FUJIFILM Irvine Scientific
- Genea Limited
- Nidacon International AB
- Celmatix Inc.
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1Preface
1.1Objectives of the Study
1.2Key Assumptions
1.3Report Coverage - Key Segmentation and Scope
1.4Research Methodology
2Executive Summary
3Global Assisted Reproductive Technology Market Overview
3.1Global Assisted Reproductive Technology Market Historical Value (2017-2023)
3.2Global Assisted Reproductive Technology Market Forecast Value (2024-2032)
4Global Assisted Reproductive Technology Market Landscape
4.1Global Assisted Reproductive Technology: Developers Landscape
4.1.1Analysis by Year of Establishment
4.1.2Analysis by Company Size
4.1.3Analysis by Region
4.2Global Assisted Reproductive Technology: Product Landscape
4.2.1Analysis by Type
4.2.2Analysis by Technology
4.2.3Analysis by Applications
5Global Assisted Reproductive Technology Market Dynamics
5.1Market Drivers and Constraints
5.2SWOT Analysis
5.3Porter's Five Forces Model
5.4Key Demand Indicators
5.5Key Price Indicators
5.6Industry Events, Initiatives, and Trends
5.7Value Chain Analysis
6Global Assisted Reproductive Technology Market Segmentation
6.1Global Assisted Reproductive Technology Market by Procedure
6.1.1Market Overview
6.1.2Fresh Donor
6.1.3Fresh Nondonor
6.1.4Frozen Donor
6.1.5Frozen Nondonor
6.1.6Embryo/Egg Banking
6.2Global Assisted Reproductive Technology Market by Age
6.2.1Market Overview
6.2.2Women Younger Than Age 35
6.2.3Women Older Than Age 35
6.3Global Assisted Reproductive Technology Market by Application
6.3.1Market Overview
6.3.2Artificial Insemination - Intrauterine Insemination (AI-IUI)
6.3.3Frozen Embryo Replacement (FER)
6.3.4Surrogacy
6.3.5Ovulation Induction
6.3.6Others
6.4Global Assisted Reproductive Technology Market by End User
6.4.1Market Overview
6.4.2Hospitals
6.4.3Fertility Clinics
6.4.4Others
6.5Global Assisted Reproductive Technology Market by Region
6.5.1Market Overview
6.5.2North America
6.5.3Europe
6.5.4Asia Pacific
6.5.5Latin America
6.5.6Middle East and Africa
7North America Assisted Reproductive Technology Market
7.1Market Share by Country
7.2United States of America
7.3Canada
8Europe Assisted Reproductive Technology Market
8.1Market Share by Country
8.2United Kingdom
8.3Germany
8.4France
8.5Italy
8.6Others
9Asia Pacific Assisted Reproductive Technology Market
9.1Market Share by Country
9.2China
9.3Japan
9.4India
9.5ASEAN
9.6Australia
9.7Others
10Latin America Assisted Reproductive Technology Market
10.1Market Share by Country
10.2Brazil
10.3Argentina
10.4Mexico
10.5Others
11Middle East and Africa Assisted Reproductive Technology Market
11.1Market Share by Country
11.2Saudi Arabia
11.3United Arab Emirates
11.4Nigeria
11.5South Africa
11.6Others
12Regulatory Framework
12.1Regulatory Overview
12.1.1US FDA
12.1.2EU EMA
12.1.3INDIA CDSCO
12.1.4JAPAN PMDA
12.1.5Others
13Patent Analysis
13.1Analysis by Type of Patent
13.2Analysis by Publication year
13.3Analysis by Issuing Authority
13.4Analysis by Patent Age
13.5Analysis by CPC Analysis
13.6Analysis by Patent Valuation
13.7Analysis by Key Players
14Grants Analysis
14.1Analysis by year
14.2Analysis by Amount Awarded
14.3Analysis by Issuing Authority
14.4Analysis by Grant Application
14.5Analysis by Funding Institute
14.6Analysis by NIH Departments
14.7Analysis by Recipient Organization
15Funding and Investment Analysis
15.1Analysis by Funding Instances
15.2Analysis by Type of Funding
15.3Analysis by Funding Amount
15.4Analysis by Leading Players
15.5Analysis by Leading Investors
15.6Analysis by Geography
16Partnership and Collaborations Analysis
16.1Analysis by Partnership Instances
16.2Analysis by Type of Partnership
16.3Analysis by Leading Players
16.4Analysis by Geography
17Supplier Landscape
17.1California Cryobank
17.1.1Financial Analysis
17.1.2Product Portfolio
17.1.3Demographic Reach and Achievements
17.1.4Mergers and Acquisitions
17.1.5Certifications
17.2Bloom Fertility Centre
17.2.1Financial Analysis
17.2.2Product Portfolio
17.2.3Demographic Reach and Achievements
17.2.4Mergers and Acquisitions
17.2.5Certifications
17.3Anecova
17.3.1Financial Analysis
17.3.2Product Portfolio
17.3.3Demographic Reach and Achievements
17.3.4Mergers and Acquisitions
17.3.5Certifications
17.4CooperSurgical
17.4.1Financial Analysis
17.4.2Product Portfolio
17.4.3Demographic Reach and Achievements
17.4.4Mergers and Acquisitions
17.4.5Certifications
17.5Merck KGaA
17.5.1Financial Analysis
17.5.2Product Portfolio
17.5.3Demographic Reach and Achievements
17.5.4Mergers and Acquisitions
17.5.5Certifications
17.6Ferring B.V.
17.6.1Financial Analysis
17.6.2Product Portfolio
17.6.3Demographic Reach and Achievements
17.6.4Mergers and Acquisitions
17.6.5Certifications
17.7FUJIFILM Irvine Scientific
17.7.1Financial Analysis
17.7.2Product Portfolio
17.7.3Demographic Reach and Achievements
17.7.4Mergers and Acquisitions
17.7.5Certifications
17.8Genea Limited
17.8.1Financial Analysis
17.8.2Product Portfolio
17.8.3Demographic Reach and Achievements
17.8.4Mergers and Acquisitions
17.8.5Certifications
17.9Nidacon International AB
17.9.1Financial Analysis
17.9.2Product Portfolio
17.9.3Demographic Reach and Achievements
17.9.4Mergers and Acquisitions
17.9.5Certifications
17.10Celmatix Inc.
17.10.1Financial Analysis
17.10.2Product Portfolio
17.10.3Demographic Reach and Achievements
17.10.4Mergers and Acquisitions
17.10.5Certifications
18Key Opinion Leaders (KOL) Insights (Additional Insight)
19Company Competitiveness Analysis (Additional Insight)
19.1Very Small Companies
19.2Small Companies
19.3Mid-Sized Companies
19.4Large Companies
19.5Very Large Companies
20Payment Methods (Additional Insight)
20.1Government Funded
20.2Private Insurance
20.3Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.